Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma

NCT00566098 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

BIOLOGICAL: MILs
DRUG: Melphalan
BIOLOGICAL: PCV13

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]